Which Ante Mortem Clinical Features Predict Progressive Supranuclear Palsy Pathology?

Autor: Respondek, Gesine, Kurz, Carolin, Arzberger, Thomas, Compta, Yaroslau, Englund, Elisabet, Ferguson, Leslie W, Gelpi, Ellen, Giese, Armin, Irwin, David J, Meissner, Wassilios G, Nilsson, Christer, Pantelyat, Alexander, Rajput, Alex, Van Swieten, John C, Troakes, Claire, Josephs, Keith A, Lang, Anthony E, Mollenhauer, Brit, Müller, Ulrich, Whitwell, Jennifer L, Antonini, Angelo, Bhatia, Kailash P, Bordelon, Yvette, Corvol, Jean-Christophe, Colosimo, Carlo, Dodel, Richard, Grossman, Murray, Kassubek, Jan, Krismer, Florian, Levin, Johannes, Lorenzl, Stefan, Morris, Huw, Nestor, Peter, Oertel, Wolfgang H, Rabinovici, Gil D, Rowe, James B, Van Eimeren, Thilo, Wenning, Gregor K, Boxer, Adam, Golbe, Lawrence I, Litvan, Irene, Stamelou, Maria, Höglinger, Günter U, Movement Disorder Society-Endorsed PSP Study Group

Publikováno v: Movement Disorders, 32(7), 995-1005. John Wiley & Sons Inc.
Movement disorders : official journal of the Movement Disorder Society, vol 32, iss 7
Movement disorders 32(7), 995-1005 (2017). doi:10.1002/mds.27034
Respondek, G; Kurz, C; Arzberger, T; Compta, Y; Englund, E; Ferguson, LW; et al.(2017). Which Ante Mortem Clinical Features Predict Progressive Supranuclear Palsy Pathology?. MOVEMENT DISORDERS, 32(7), 995-1005. doi: 10.1002/mds.27034. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/8qc544hm

BACKGROUND: Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting with a broad spectrum of clinical phenotypes. OBJECTIVE: To identify clinical features and investigations that predict or exclude PSP pathology durin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::534a8b3521c58d5338bfc22bc143b685
https://pure.eur.nl/en/publications/d041780e-a62b-4a30-af32-d06c70c3cf55

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy

Autor: David J. Irwin, Kailash P. Bhatia, Sigrun Roeber, Jennifer L. Whitwell, Claire Troakes, Alexander Pantelyat, Günter U. Höglinger, Jan Kassubek, Ines Piot, John C. van Swieten, Thomas Arzberger, Alex Rajput, Angelo Antonini, Leslie W. Ferguson, Werner Poewe, Irene Litvan, Thilo van Eimeren, Max-Joseph Grimm, Carlo Colosimo, Ellen Gelpi, Johannes Levin, Gesine Respondek, Adam L. Boxer, Jean-Christophe Corvol, Wassilios G. Meissner, Lawrence I. Golbe, Huw R. Morris, James B. Rowe, Christer Nilsson, Maria Stamelou, Gregor K. Wenning, Murray Grossman, Wolfgang H. Oertel, Anthony E. Lang, Yaroslau Compta, Keith A. Josephs, Armin Giese

Publikováno v: Movement Disorders, 34(8), 1228-1232. John Wiley & Sons Inc.
Grimm, Max-Joseph; Respondek, Gesine; Stamelou, Maria; Arzberger, Thomas; Ferguson, Leslie; Gelpi, Ellen; et al.(2019). How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.. Movement disorders : official journal of the Movement Disorder Society. doi: 10.1002/mds.27666. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/6f11m0q4
Movement disorders : official journal of the Movement Disorder Society, vol 34, iss 8
Movement disorders 34(8), 1228-1232 (2019). doi:10.1002/mds.27666

BACKGROUND: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnostic allocations, stratified by certainty levels and clinical predominance types. We aimed to study the frequency of ambiguous multiple allocations and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e6247bd0a97debed13faf66b517abb
https://doi.org/10.1002/mds.27666

Clinical Conditions 'Suggestive of Progressive Supranuclear Palsy'—Diagnostic Performance

Autor: Grimm, M.-J. Respondek, G. Stamelou, M. Arzberger, T. Ferguson, L. Gelpi, E. Giese, A. Grossman, M. Irwin, D.J. Pantelyat, A. Rajput, A. Roeber, S. van Swieten, J.C. Troakes, C. Meissner, W.G. Nilsson, C. Piot, I. Compta, Y. Rowe, J.B. Höglinger, G.U. for the Movement Disorder Society-Endorsed PSP Study Group

Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy introduced the diagnostic certainty level “suggestive of progressive supranuclear palsy” for clinical conditions with subtle signs, suggestive of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c013e72d67c328fcf38918d4b6bcf74d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997395

Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria

Autor: Höglinger, Günter U, Respondek, Gesine, Arzberger, Thomas, Englund, Elisabet, Gelpi, Ellen, Giese, Armin, Irwin, David J, Meissner, Wassilios G, Pantelyat, Alexander, Rajput, Alex, van Swieten, John C, Troakes, Claire, Stamelou, Maria, Antonini, Angelo, Bhatia, Kailash P, Bordelon, Yvette, Compta, Yaroslau, Corvol, Jean-Christophe, Colosimo, Carlo, Dickson, Dennis W, Ferguson, Leslie, Grossman, Murray, Kassubek, Jan, Kurz, Carolin, Krismer, Florian, Lorenzl, Stefan, Morris, Huw R, Poewe, Werner, Rabinovici, Gil, Rowe, James B, Schellenberg, Gerard D, Seppi, Klaus, van Eimeren, Thilo, Wenning, Gregor K, Josephs, Keith A, Boxer, Adam L, Golbe, Lawrence I, Litvan, Irene, Group, Movement Disorder Society-endorsed PSP Study, Lang, Anthony E, Mollenhauer, Brit, Kurz, Caroline, Nilsson, Christer, Whitwell, Jennifer L, Levin, Johannes, van Swieten, John, Müller, Ulrich, Nestor, Peter, Dodel, Richard, Oertel, Wolfgang H

Publikováno v: Hoeglinger, GU; Respondek, G; Stamelou, M; Kurz, C; Josephs, KA; Lang, AE; et al.(2017). Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria. MOVEMENT DISORDERS, 32(6), 853-864. doi: 10.1002/mds.26987. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/32h6q2j6
Movement Disorders, 32(6), 853-864. John Wiley & Sons Inc.
Movement disorders 32(6), 853-864 (2017). doi:10.1002/mds.26987
Movement disorders : official journal of the Movement Disorder Society, vol 32, iss 6

BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1ceac96a84b9265831a303f5bde9fe7c
http://www.escholarship.org/uc/item/32h6q2j6

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Autor: Höglinger, G.U. Respondek, G. Stamelou, M. Kurz, C. Josephs, K.A. Lang, A.E. Mollenhauer, B. Müller, U. Nilsson, C. Whitwell, J.L. Arzberger, T. Englund, E. Gelpi, E. Giese, A. Irwin, D.J. Meissner, W.G. Pantelyat, A. Rajput, A. van Swieten, J.C. Troakes, C. Antonini, A. Bhatia, K.P. Bordelon, Y. Compta, Y. Corvol, J.-C. Colosimo, C. Dickson, D.W. Dodel, R. Ferguson, L. Grossman, M. Kassubek, J. Krismer, F. Levin, J. Lorenzl, S. Morris, H.R. Nestor, P. Oertel, W.H. Poewe, W. Rabinovici, G. Rowe, J.B. Schellenberg, G.D. Seppi, K. van Eimeren, T. Wenning, G.K. Boxer, A.L. Golbe, L.I. Litvan, I. Wenning, G.K. Höglinger, G.U. Morris, H.R. Litvan, I. Kassubek, J. Corvol, J.-C. Whitwell, J.L. Levin, J. van Swieten, J. Bhatia, K.P. Josephs, K.A. Seppi, K. Golbe, L.I. Grossman, M. Dodel, R. Lorenzl, S. van Eimeren, T. Arzberger, T. Müller, U. Poewe, W. Oertel, W.H. Compta, Y. Bordelon, Y. the Movement Disorder Society-endorsed PSP Study Group

Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::84faa14dccb2035a5f4234038467022e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2998304